.jpg "Virologist network reaffirms support for mRNA vaccine platform")
Virologist network reaffirms support for mRNA vaccine platform
An international virologist group representing more than 80 research labs across more than 40 countries yesterday reaffirmed their support for...
Year: 2025
A recent common cold may nearly halve risk of COVID-19, study suggests
Jennifer Oosthuizen / CDC A study in Israel confirms antibiotic use as a major risk factor for Clostridioides difficile infection...
COVID pandemic disrupted progress in routine child, teen vaccination rates, data suggest
A study published today in Pediatrics shows that since the COVID-19 pandemic began, routine childhood and adolescent vaccination has fallen off...
Study: Kidney-transplant recipients benefit from COVID-19 vaccination
Jennifer Oosthuizen / CDC A study in Israel confirms antibiotic use as a major risk factor for Clostridioides difficile infection...
Immunologic study shows rebound of other viruses after COVID measures lifted
The lifting of COVID-19 prevention measures such as masking and social distancing, which also tamped down the circulation of other...
US COVID activity gains more steam
iStock US adults with long COVID had higher rates of additional hospitalization in the 6 months after acute infection compared...
Study examines impact of long COVID on healthcare use
iStock US adults with long COVID had higher rates of additional hospitalization in the 6 months after acute infection compared...
Study: mRNA COVID vaccines cost-effective for US seniors, and under some scenarios, younger adults
Today in JAMA Network Open, University of Michigan-led research suggests that the US 2023-24 mRNA COVID-19 vaccines were cost-effective for people...
Study: Risk of RSV not heightened in kids with recent COVID infections
Pediatric hospitals across the United States saw a surge in respiratory syncytial virus (RSV) in the summer of 2021 and...
HHS scraps further work on life-saving mRNA vaccine platform
Andrew Pekosz, PhD, professor and vice chair at Johns Hopkins University, said on X that while mRNA vaccine technology isn't perfect,...